Skip to main content
Figure 4 | Cardiovascular Diabetology

Figure 4

From: Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis

Figure 4

Western blot showing altered expression of calcium and ROS regulatory proteins in control, diabetic rats and diabetic rats treated with AZL (5 mg kg-1 day-1). A: Troponin I, B: RyR-2 and SERCA2ATPase, C: p67phox and Mn-SOD. Image is representative of the best of three separate experiments. β-actin served as loading control. Normalized densitometric quantification has been depicted by numerical value below the bands.

Back to article page